Karman Holdings Inc. KRMN 深 沪
等待开盘 07-02 09:30:00 美东时间
54.93
+5.010
+10.04%
华盛通- 最 高55.22
- 今 开50.77
- 成交量 478.67万股
- 最 低 50.5332
- 昨 收 49.92
- 总市值 72.80亿
- 52周最高 118.38
- 市盈率 静 418.67
- 换手率 3.61%
- 52周最低 44.00
- 委 比 -36.05%
- 总股本 1.33亿
- 历史最高 118.38
- 量 比 1.62
- 振 幅 9.39%
- 历史最低 25.025
- 每 手 1
- 风险率 18.50%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 潜在涨幅392.61%！Chardan Capital维持EyePoint"买入"评级，上调目标价至65美元
今日重点评级关注：Chardan Capital：维持EyePoint"买入"评级，目标价从29美元升至65美元；康托·菲茨杰拉德：维持Hyperliquid Strategies"超配"评级，目标价从8美元升至18.4美元
44分钟前
9 Industrials Stocks With Whale Alerts In Today’s Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner. Traders will search for circumstances when the market estimation of an option diverges heavily...
今天 01:35
Citigroup Maintains Buy on Karman Holdings, Lowers Price Target to $76
Citigroup analyst John Godyn maintains Karman Holdings (NYSE:KRMN) with a Buy and lowers the price target from $97 to $76.
07-01 22:31
William Blair updates conviction list: Oracle in, Meta out and more
William Blair added Oracle (ORCL), American Express (AXP), Ecolab (ECL), Comfort Systems USA (FIX), Boot Barn (BOOT), LifeStance Health (LFST), Genmab (GMAB), Silence Therapeutics (SLN), Tyra Bioscien...
07-01 19:26
William Blair updates its Conviction List
William Blair has updated its Conviction List of stock picks for June. Analysts added Cloudflare (NET), Fastenal (FAST) and Ethos Technologies (LIFE), while removing Guardant Health (GH), AAON (AAON) ...
06-02 17:19
Karman prices upsized secondary offering of 14,000,000 shares at $61 each
Karman prices upsized secondary offering of 14,000,000 shares at $61 each Karman Holdings priced an upsized secondary offering of 14,000,000 common shares at USD 61 per share. Gross proceeds to selling stockholders set at about USD 854 million; Karman will not receive any proceeds. Offering increase
05-29 11:35
美股大行评级 | Cava、CrowdStrike、Keysight获多家大行上调目标价；家得宝绩后遭多家大行下调目标价
今日重点评级关注：Oppenheimer：维持Protara Therapeutics"跑赢大市"评级，目标价从25美元升至28美元；Piper Sandler：维持Bright Minds Biosciences"超配"评级，目标价从190美元升至220美元
05-21 12:05
Keybanc Maintains Overweight on Karman Holdings, Lowers Price Target to $100
Keybanc analyst Michael Leshock maintains Karman Holdings (NYSE:KRMN) with a Overweight and lowers the price target from $122 to $100.
05-20 22:46
美股大行评级 | 最高1100美元，花旗、瑞穗、 Melius Research齐上调美光目标价；X-Energy获大小摩等多家机构首予“买入”评级
今日重点评级关注：TD Cowen：维持Strategy"买入"评级，目标价从395美元升至400美元；摩根士丹利：维持Cipher Digital"超配"评级，目标价从40.5美元升至42.5美元
05-20 11:55
